KALA — KALA BIO Cashflow Statement
0.000.00%
Last trade - 00:00- $9.20m
- $5.55m
Annual cashflow statement for KALA BIO, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -104 | -143 | -44.8 | -42.2 | -38.5 |
| Depreciation | |||||
| Non-Cash Items | 16.3 | 44 | -35.1 | 5.07 | 10.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.57 | -10.6 | 0.491 | 8.89 | -1.78 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -90.7 | -108 | -78.9 | -27.9 | -29.4 |
| Capital Expenditures | -1.94 | -0.886 | -0.313 | -0.61 | -0.208 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -76.3 | 71.7 | 63 | 0.181 | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -78.2 | 70.8 | 62.7 | -0.429 | -0.208 |
| Financing Cash Flow Items | — | — | — | -2.04 | -0.119 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 161 | 42.6 | -7.94 | 8.51 | 29.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -8.28 | 5.12 | -24.1 | -19.9 | 0.286 |